Monday Morning Medicine Podcast.
Posted by Trevor on 13 July 2014 | 4 Comments
From the perspective of Three Simple Steps it has been a busy week. To those who purchased the guided Intention or guided TQT from http://www.physicsofsuccess.net this week thank you for your positive feedback and also for directly contributing to cancer R&D. Special thanks to those who signed up for the next Physics of success course due to start in August. Not only is it a life transforming experience, but in changing your own lives you contribute significantly to changing the lives of others with the funds raised. If you have not yet attended this course, but feel stuck in quicksand or out of control of your life then I urge you to make the commitment. The feedback from every attendee to date has been uniform and summarized in the phrase life-changing, life-freeing.
One person who signed up this week asked me what I mean exactly when I say all proceeds go to cancer R&D? Words are cheap and recently several large charities have come in for criticism because of the salaries and expenses paid to their executives. In one particularly disturbing case the charity founder was using the funds to pay for his children’s private schooling. So, I appreciated the request for clarification.
All proceeds from my Three Simple Steps royalties, (averages $1 per book), the supporting products such as the guided intentions (averages $80) and guided TQT (averages $25), and all proceeds from the Physics of Success classes (averages $150 per attendee) go directly to cancer research and development via a project called Neovia.
Neovia (new way) was set up to develop new cancer treatments that are equally effective or more effective than currently used treatments, but with lower side effects caused to the person taking the treatment.
There are two leading candidates going through clinical testing, one is a modified compound from African maple leaf. The other is a modified compound from crocus petal. Both have long been known to have strong anti tumor activity but were also highly toxic to healthy cells. Many years ago several large pharmaceutical companies tried and failed to make them into useful medicines, spending several hundred million in the process.
A few years ago ingenious compound modifications made by a brilliant physician in San Francisco maintain the anti tumor capacity and eliminate the toxicity making it theoretically possible to overcome the limitations that the large pharma companies encountered.
The traditional cancer treatment development model in the world today, however, is not structured in a way that could see these candidates emerge. It now takes $5 billion to bring a treatment from invention through FDA approval and into the doctor’s hands. Why so much? Well only 1 in every 5000 inventions survives the strict FDA criteria, and the path takes up to 15 years. The cost of all those failures has to be recouped by the traditional business, which eventually results in high-priced treatments. Also decades of merger and acquisition has created a handful of global mega companies that have armies of highly compensated staff, and hugely expensive facilities. Corporate wastefulness of funds is endemic and was brought home to me a few years ago when I attended an executive summit for R&D experts who spent a week debating the high costs of R&D. Over half of them flew to the summit in a corporate jet and spent every afternoon on the golf course reclaiming the costs as meeting expenses.
This high cost of R&D failure and corporate wastefulness also means that companies now have to overlook potential treatments for more rare illnesses and instead work only on treatments for larger markets that can return the high costs in a shorter timeframe. It is a flawed model, but it is what it is. Complaining about it does nothing but compound the problem. Instead I am for a better solution.
At Neovia, we go about the same process in a unique way. We have no facilities of our own but contract with labs around the world wherever we can get a great deal. Neovia is the worlds first fully virtual R&D model. We have no employees and everyone working on the projects does so in their spare time and for the privilege of doing he right thing. There are no profits, bonuses or expenses paid to anyone. The bulk of the project expenses are paid by the personal funds of two people, myself and a friend and fellow serial entrepreneur, also a master Buddhist, Raymond Su.
Additionally, every cent of proceeds from Three Simple Steps royalties, and its support products and course goes directly into the Neovia project to pay for actual clinical testing. So, you know that every cent or penny of your hard earned money is making a huge difference in the world. In a cynical world where everyone seems to have an angle or ulterior motive when doing something positive, this is a unique proposition a rare, transparent win-win. When you purchase a product you make a positive difference in life, and the product whether TSS itself, the guided intention or TQT, or the course makes a positive difference in your life.
The challenge of doing it this way is that no money is ever spent on marketing activity for the book, guides or course. The intelligent optimist advertises the book and soon will advertise the course for free. Radio and TV support has been purely organic, and actual sales are by word of mouth. That success is down to you… those who signed up to receive these podcasts and articles. I know many of you recommend TSS and the course to friends and family or to your clubs and hobbies or work colleagues. Volunteers have helped with technical support. Others help with social media promotions and strategies. The result is amazing. This week I received emails from Australia, Mexico and Slovakia. How wonderful is that?
I also received four free copies of TSS from the publishers in its new Spanish translation. If you would like a Spanish copy go to http://oceano.mx/buscar.aspx?q=très+simples+pasos
Whatever you have done to contribute to the success of Three Simple Steps, it is appreciated by me but also everyone who discovers the book or course for the first time. And on top of that you also contribute directly to continuing the development of promising cancer treatments.